PharmaShots | Incisive News in 3 Shots

Subscribe Now

north america

SanBio and Sumitomo Dainippon Pharma Terminate Joint Development and License Agreement for SB623 in North America

SanBio and Sumitomo Dainippon Pharma Terminate Joint Development and License Agreement for SB623 in North America

December 16, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us